CANF Annual Interest Expense
N/A
31 December 2023
Summary:
CANF annual interest expense is not available.CANF Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CANF Quarterly Interest Expense
N/A
30 June 2024
Summary:
CANF quarterly interest expense is not available.CANF Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CANF TTM Interest Expense
N/A
30 June 2024
Summary:
CANF TTM interest expense is not available.CANF TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CANF Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
CANF Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
Can-Fite BioPharma Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | $157.00 K(-0.6%) | $444.00 K(+20.3%) |
| June 2019 | - | $158.00 K(+21.5%) | $369.00 K(-11.7%) |
| Mar 2019 | - | $130.00 K(<-9900.0%) | $418.00 K(-2.1%) |
| Dec 2018 | $427.00 K(>+9900.0%) | - | - |
| Dec 2018 | - | -$1000.00(-101.2%) | $427.00 K(+205.0%) |
| Sept 2018 | - | $82.00 K(-60.4%) | $140.00 K(+241.5%) |
| June 2018 | - | $207.00 K(+48.9%) | $41.00 K(-62.0%) |
| Mar 2018 | - | $139.00 K(-148.3%) | $108.00 K(>+9900.0%) |
| Dec 2017 | $0.00(0.0%) | - | - |
| Dec 2017 | - | -$288.00 K(+1594.1%) | $0.00(-100.0%) |
| Sept 2017 | - | -$17.00 K(-106.2%) | -$87.80 K(-156.3%) |
| June 2017 | - | $274.00 K(+783.9%) | $155.90 K(-144.6%) |
| Mar 2017 | - | $31.00 K(-108.2%) | -$349.30 K(<-9900.0%) |
| Dec 2016 | $0.00 | - | - |
| Dec 2016 | - | -$375.80 K(-265.8%) | $100.00(-100.0%) |
| Sept 2016 | - | $226.70 K(-198.1%) | $375.90 K(-66.5%) |
| June 2016 | - | -$231.20 K(-160.8%) | $1.12 M(-30.5%) |
| Mar 2016 | - | $380.40 K(-60.8%) | $1.61 M(+45.0%) |
| Sept 2015 | - | $971.50 K(+271.8%) | $1.11 M(+1979.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2015 | - | $261.30 K(+5706.7%) | $53.50 K(+259.1%) |
| Mar 2015 | - | $4500.00(-103.6%) | $14.90 K(-0.7%) |
| Dec 2014 | $14.90 K(-94.2%) | - | - |
| Dec 2014 | - | -$124.80 K(+42.6%) | $15.00 K(-94.8%) |
| Sept 2014 | - | -$87.50 K(-139.3%) | $291.10 K(-29.8%) |
| June 2014 | - | $222.70 K(+4741.3%) | $414.80 K(+89.0%) |
| Mar 2014 | - | $4600.00(-97.0%) | $219.50 K(-68.5%) |
| Dec 2013 | $256.10 K(+3456.9%) | $151.30 K(+318.0%) | $696.10 K(+44.7%) |
| Sept 2013 | - | $36.20 K(+32.1%) | $481.20 K(-5.5%) |
| June 2013 | - | $27.40 K(-94.3%) | $509.20 K(+0.9%) |
| Mar 2013 | - | $481.20 K(-856.6%) | $504.80 K(+2039.0%) |
| Dec 2012 | $7200.00(-45.0%) | - | - |
| Dec 2012 | - | -$63.60 K(-199.1%) | $23.60 K(-72.9%) |
| Sept 2012 | - | $64.20 K(+179.1%) | $87.20 K(+279.1%) |
| June 2012 | - | $23.00 K(+36.1%) | $23.00 K(-33.5%) |
| Dec 2011 | $13.10 K(+79.5%) | - | - |
| June 2011 | - | $16.90 K(-4.5%) | $34.60 K(+95.5%) |
| Mar 2011 | - | $17.70 K | $17.70 K |
| Dec 2010 | $7300.00 | - | - |
FAQ
- What is the all time high annual interest expense for Can-Fite BioPharma?
- What is the all time high quarterly interest expense for Can-Fite BioPharma?
- What is the all time high TTM interest expense for Can-Fite BioPharma?
What is the all time high annual interest expense for Can-Fite BioPharma?
Can-Fite BioPharma all-time high annual interest expense is $427.00 K
What is the all time high quarterly interest expense for Can-Fite BioPharma?
Can-Fite BioPharma all-time high quarterly interest expense is $971.50 K
What is the all time high TTM interest expense for Can-Fite BioPharma?
Can-Fite BioPharma all-time high TTM interest expense is $1.61 M